Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Gorman

Showing results (301-310 of 324) with videos related to

Pageof 33
Sort By:
Annals of Clinical and Translational Neurology|January 28, 2021
Anakinra usage in febrile infection related epilepsy syndrome: an international cohortYi-Chen Lai, Eyal Muscal, Elizabeth Wells, et al.
Annals of Clinical and Translational Neurology|November 13, 2023
Short-chain fatty acid producers in the gut are associated with pediatric multiple sclerosis onsetVinicius A Schoeps, Xiaoyuan Zhou, Mary K Horton, et al.
Neurology|June 13, 2014
Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS diseaseRussell C Dale, Fabienne Brilot, Lisa V Duffy, et al.
Annals of Clinical and Translational Neurology|August 19, 2021
Gut microbiome is associated with multiple sclerosis activity in childrenMary K Horton, Kathryn McCauley, Douglas Fadrosh, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 7, 2026
Telomere length as a marker of biological age in paediatric multiple sclerosisKayla Jacques, Jonathan Race, Christopher Goyne, et al.
Annals of Neurology|April 25, 2022
ZSCAN1 Autoantibodies Are Associated with Pediatric Paraneoplastic ROHHADCaleigh Mandel-Brehm, Leslie A Benson, Baouyen Tran, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 24, 2021
International Consensus Recommendations for the Treatment of Pediatric NMDAR Antibody EncephalitisMargherita Nosadini, Terrence Thomas, Michael Eyre, et al.
Annals of Neurology|November 6, 2025
Real-World Effectiveness of Switching to Oral or Infusion Versus Injectable Disease-Modifying Therapy in Pediatric Multiple SclerosisAaron W Abrams, Michael Waltz, T Charles Casper, et al.
Annals of Neurology|September 11, 2022
MOG and AQP4 Antibodies among Children with Multiple Sclerosis and ControlsCristina M Gaudioso, Soe Mar, T Charles Casper, et al.
Neurology|November 12, 2024
Epidemiology and Impact of Social Hardships in Children With Multiple Sclerosis in the United StatesElizabeth Wilson, Huong D Meeks, Bradley J Barney, et al.
Pageof 33

Showing results (301-310 of 324) with videos related to

Sort By:
Pageof 33
Annals of Clinical and Translational Neurology|January 28, 2021
Anakinra usage in febrile infection related epilepsy syndrome: an international cohortYi-Chen Lai, Eyal Muscal, Elizabeth Wells, et al.
Annals of Clinical and Translational Neurology|November 13, 2023
Short-chain fatty acid producers in the gut are associated with pediatric multiple sclerosis onsetVinicius A Schoeps, Xiaoyuan Zhou, Mary K Horton, et al.
Neurology|June 13, 2014
Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS diseaseRussell C Dale, Fabienne Brilot, Lisa V Duffy, et al.
Annals of Clinical and Translational Neurology|August 19, 2021
Gut microbiome is associated with multiple sclerosis activity in childrenMary K Horton, Kathryn McCauley, Douglas Fadrosh, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 7, 2026
Telomere length as a marker of biological age in paediatric multiple sclerosisKayla Jacques, Jonathan Race, Christopher Goyne, et al.
Annals of Neurology|April 25, 2022
ZSCAN1 Autoantibodies Are Associated with Pediatric Paraneoplastic ROHHADCaleigh Mandel-Brehm, Leslie A Benson, Baouyen Tran, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 24, 2021
International Consensus Recommendations for the Treatment of Pediatric NMDAR Antibody EncephalitisMargherita Nosadini, Terrence Thomas, Michael Eyre, et al.
Annals of Neurology|November 6, 2025
Real-World Effectiveness of Switching to Oral or Infusion Versus Injectable Disease-Modifying Therapy in Pediatric Multiple SclerosisAaron W Abrams, Michael Waltz, T Charles Casper, et al.
Annals of Neurology|September 11, 2022
MOG and AQP4 Antibodies among Children with Multiple Sclerosis and ControlsCristina M Gaudioso, Soe Mar, T Charles Casper, et al.
Neurology|November 12, 2024
Epidemiology and Impact of Social Hardships in Children With Multiple Sclerosis in the United StatesElizabeth Wilson, Huong D Meeks, Bradley J Barney, et al.
Pageof 33